Hydrogenobyrinic acid, a modified tetrapyrrole composed
of eight
five-carbon compounds, is a key intermediate and central framework
of vitamin B12. Synthesis of hydrogenobyrinic acid requires
eight S-adenosyl-methionine working as the methyl
group donor catalyzed by 12 enzymes including six methyltransferases,
causing the great shortage of S-adenosyl-methionine
and accumulation of S-adenosyl-homocysteine, which
is uneconomic and unsustainable for the cascade reaction. Here, we
report a cell-free synthetic system for producing hydrogenobyrinic
acid by integrating 12 enzymes using 5-aminolevulininate as a substrate
and develop a novel S-adenosyl-methionine regeneration
system to steadily supply S-adenosyl-methionine and
avoid the accumulated inhibition of S-adenosyl-homocysteine
by consuming a cheaper substrate (l-methionine and polyphosphate).
By combination of the reaction system optimization and S-adenosyl-methionine regeneration, the titer of hydrogenobyrinic
acid was improved from 0.61 to 29.39 mg/L in a 12 h reaction period,
representing an increase of 48.18-fold, raising an efficient and rapidly
evolutional alternative method to produce high-value-added compounds
and intermediate products.